CLINICAL TRIALS PROFILE FOR DEXEDRINE
✉ Email this page to a colleague
All Clinical Trials for DEXEDRINE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00296686 ↗ | Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression | Terminated | New York State Psychiatric Institute | Phase 4 | 2001-09-01 | This pilot study will assess the efficacy of several sequential pharmacological treatments for patients with Refractory Depression. |
| NCT00363298 ↗ | Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD | Completed | Obsessive Compulsive Foundation | N/A | 2006-08-01 | The study hypothesis is that dextro-amphetamine (d-amphetamine) will be safe and effective when used to augment treatment for Obsessive-Compulsive Disorder (OCD), and that tolerance (loss of therapeutic effect) to the medication will not develop over a period of several weeks. |
| NCT00363298 ↗ | Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD | Completed | Stanford University | N/A | 2006-08-01 | The study hypothesis is that dextro-amphetamine (d-amphetamine) will be safe and effective when used to augment treatment for Obsessive-Compulsive Disorder (OCD), and that tolerance (loss of therapeutic effect) to the medication will not develop over a period of several weeks. |
| NCT00439049 ↗ | Substance Abuse Pre-Treatment Screening Study | Recruiting | National Institute on Drug Abuse (NIDA) | 2005-10-01 | The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted. | |
| NCT00439049 ↗ | Substance Abuse Pre-Treatment Screening Study | Recruiting | The University of Texas Health Science Center, Houston | 2005-10-01 | The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted. | |
| NCT00794625 ↗ | Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study) | Unknown status | Northwell Health | Phase 4 | 2008-11-01 | This study will determine the advantages and disadvantages of adding one of two different types of drugs to stimulant treatment for reducing aggressive behavior in children with attention deficit with hyperactivity disorder (ADHD). |
| NCT00794625 ↗ | Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study) | Unknown status | University of Texas | Phase 4 | 2008-11-01 | This study will determine the advantages and disadvantages of adding one of two different types of drugs to stimulant treatment for reducing aggressive behavior in children with attention deficit with hyperactivity disorder (ADHD). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DEXEDRINE
Condition Name
Clinical Trial Locations for DEXEDRINE
Trials by Country
Clinical Trial Progress for DEXEDRINE
Clinical Trial Phase
Clinical Trial Sponsors for DEXEDRINE
Sponsor Name
